Surrogacy Market Analysis

Type (Gestational, Traditional)

Gestational segment is estimated to dominate around 60% surrogacy market share by the end of 2037. Using the gestational surrogacy method, the intended parents' or donors' eggs and sperm are used to conceive the pregnancy, which is then carried by the surrogate. It has special advantages including removing the genetic link between the surrogate and the child, which resolves psychological and legal issues.

Additionally, same-sex couples, those interested in genetic variety, and individuals and couples with reproductive difficulties can benefit from gestational surrogacy. Also, the success rates of gestational surrogacy are increasing because to advancements in the precision of assisted reproductive technologies, namely in vitro fertilization (IVF). As per the information of National Library of Medicine; as of September 4, 2023, IVF has been used to conceive approximately 5 million children globally since 1978.

Technology (IVF with ICSI, IUI, IVF without ICSI)

By 2037, IVF with ICSI segment is projected to dominate over 38% surrogacy market share. In vitro fertilization (IVF) in conjunction with intracytoplasmic sperm injection (ICSI) is the dominant technology in the surrogacy business worldwide. In cases where conventional IVF methods may not yield the desired results, IVF with ICSI involves directly inserting a single sperm into an egg to initiate fertilization.

Male infertility has been found to benefit greatly from this approach. These days, many couples who are experiencing infertility choose to use this approach. It has become a dominant category due to its ability to treat a variety of infertility disorders and its consistently high success rates. More than 8 million IVF babies have been born, and more than 2.5 million cycles are carried out annually, translating into more than 500,000 births.

Our in-depth analysis of the global surrogacy market includes the following segments: